SkyKick Releases Major Platform Upgrades with New Intelligent Cloud Backup Product, Revamped Security Manager, and Next-Generation Migration Suites
27.7.2023 15:00:00 EEST | Business Wire | Press release
SkyKick (https://www.skykick.com), a global leader in cloud automation and management solutions for information technology service providers (ITSPs), today announced major enhancements to its Cloud Management Platform. New products and updates deliver enhanced data protection capabilities and personalized security insights, enabling ITSPs to meet the growing demand for robust security solutions and conversations in the SMB market. This marks the biggest platform update in the company’s ten-year history.
In an era dominated by data and AI, security is a top concern for 88% of SMB customers. Despite overall IT budgets staying flat or even declining, 42% of SMB business owners are open to investing more in security and data protection solutions. SMB appetite for MSP security services continues to grow against the backdrop of increased Microsoft 365 adoption (now with an estimated 382 million commercial users worldwide) and the proliferation of sensitive data that is being created in the cloud. ITSPs are struggling to meet demand.
“As pioneers in Microsoft 365 cloud data protection and security, we closely monitor usage and adoption trends among customers and partners," said SkyKick Co-CEO Todd Schwartz. "We’re seeing that in order for ITSPs to turn customer appetite into a successful security and data protection business, they need better and more intelligent tools. Our new products make it easy for ITSPs to not only meet customer demand, but also build a successful security practice – one that is easy to sell and easy to manage."
SkyKick is announcing a reimagined Cloud Backup product, offering Intelligent Data Protection for Microsoft 365. Among the exciting new features is SmartInsights, a new capability that enhances customer engagements through insights on data growth and protection trends. Today, customers are proactively seeking to understand their data protection status. With SmartInsights, ITSPs can tap into this customer appetite and transform data protection into a valuable differentiator.
Beyond SmartInsights, the new Cloud Backup introduces a user-centric architecture that streamlines ease of use for ITSPs. Examples include a new Groups Management functionality, which scales onboarding and offboarding processes. Extending the comprehensive Microsoft 365 coverage, protection for Microsoft Planner data is now also included. Collectively, the new Cloud Backup reimagines data protection for the modern ITSP, reducing time to resolution and increasing customer satisfaction.
Additionally, SkyKick has revamped its Security Manager solution, which now has millions of SMB end-users under management since its debut in the fall of 2022.
“For partners to fully deliver on the customer promise, they need to go beyond data protection. We created Security Manager to help partners be more proactive on security and grow a stronger practice,” said SkyKick Co-CEO Evan Richman. “Today, SkyKick is announcing SecurityRadar, a key innovation within Security Manager, purpose-built to arm 100,000 Microsoft cloud partners with data-driven security insights they can use to drive proactive and personalized customer engagement.”
Beyond SecurityRadar, Security Manager is upgrading its proprietary Microsoft Partner Center Connector (PCI) with new sync technology that is 2X faster and more automated - further simplifying day-to-day customer management and Microsoft-mandated GDAP compliance.
Early market reaction to the new updates has been very positive.
“Security is a top priority for Kinetix and New Charter Technologies. We are excited about the new innovations in Security Manager, and SecurityRadar is a game-changer for us,” said Robert Herbaugh, Security and Strategy Specialist at a leading MSP. “By facilitating strong customer conversations on security, it is helping us drive increased customer value and revenue growth.”
SkyKick is also announcing the next major version of its industry-leading Migration Suites. Between a streamlined setup, a more performant sync technology, and a highly configurable new migration experience – SkyKick has reimagined the “easiest way to Microsoft 365” with even more ease, flexibility, and control for the modern ITSP.
ITSPs, as well as their customers, deserve the assurance of knowing that their technology itself is certified to be robust and enterprise-grade. Building on its numerous other certifications, the SkyKick platform and system is now certified for ISO 27001, ISO 27701 and Data Pro.
SkyKick Co-CEO Evan Richman noted, “Our fundamental vision remains to be the platform of choice for ITSPs building and growing a business around Microsoft 365. With the major enhancements that we are announcing now across Migrations, Backup, Security Manager, and Certifications, we are confident that SkyKick will help IT partners to stay ahead of challenges and deliver a truly differentiated value in the channel.”
About SkyKick
SkyKick is a global provider of cloud management software for IT Services Providers. The company is headquartered in Seattle, Wash., and has offices in Amsterdam, Sydney, and Tokyo. Its products are designed to help build successful cloud businesses by making it easy and efficient for IT providers to migrate, backup, manage and secure their customers in the cloud. Over 30,000 partners worldwide use SkyKick’s products to accelerate their cloud business, and the company has won numerous awards including being named a Microsoft Partner of the Year, 2023 IAMCP Partner of the Year, Red Herring Top 100 North America winner and one of the “100 Best Companies to Work For” in Washington State. For more information visit www.skykick.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230727023626/en/
Contact information
Paul Forecki
Voxus PR for SkyKick
skykickpr@voxuspr.com
253.208.3615
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
